Fimasartan Blood Pressure Lowering After Acute Stroke

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study evaluates the effectiveness of fimasartan-based antihypertensive treatment and prognosis in post-acute phase of ischemic stroke or transient ischemic attack patients. All participants will receive fimasartan, and the investigators will follow them up for 6 months.
Epistemonikos ID: eab0bd53b0229d8b784f1ee143f25f3eca13847c
First added on: May 21, 2024